- Q2 2024 Nykode Therapeutics ASA Earnings Call Transcript5 days agokr18.69Earnings
- Q1 2024 Nykode Therapeutics ASA Earnings Call TranscriptMay 14, 2024kr18.69Earnings
- Q4 2023 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2024kr18.69Earnings
- Q2 2023 Nykode Therapeutics ASA Earnings Call TranscriptAug 23, 2023Earnings
- Nykode Therapeutics ASA at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Nykode Therapeutics ASA Earnings Call TranscriptMay 12, 2023Earnings
- Q4 2022 Nykode Therapeutics ASA Earnings Call TranscriptFeb 28, 2023Earnings
- Nykode Therapeutics ASA Corporate Call TranscriptDec 20, 2022
- Q3 2022 Nykode Therapeutics ASA Earnings Call TranscriptNov 23, 2022Earnings
- Nykode Therapeutics ASA at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Nykode Therapeutics AS at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Vaccibody AS Call to Discuss License Agreement with Adaptive Biotechnologies Corp TranscriptJul 12, 2021
Nykode Therapeutics AS at Jefferies Healthcare Conference Transcript
Hello, everybody, good afternoon. I'd like to welcome you all again back to the 2022 Jefferies Healthcare Conference.
My name [Zed Zucker] and it is my pleasure today to be able to present to you, Michael Engsig and Agnete Fredriksen from Nykode. So I will pass it off to them.
Thank you very much. Once again, thanks for hosting us here at Jefferies. Pleased to be back.
Sure, you're all familiar with our forward-looking statements. So on that assumption, we'll move forward. I'm pleased to have with me here today, Agnete, our Co-Founder and Chief Innovation and Strategy Officer. I'm Michael Engsig, CEO of Nykode Therapeutics.
So for those of you who are not familiar with Nykode Therapeutics, Nykode is a clinical-stage immunotherapy company entirely focused on exploring and exploiting our proprietary immunotherapy platform, which uniquely targets the antigen presenting cells, which in turn results in a fast strong and long-lasting immune response.
We have a healthy mix
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)